Your browser doesn't support javascript.
loading
Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.
Spaan, András N; Schiepers, Ariën; de Haas, Carla J C; van Hooijdonk, Davy D J J; Badiou, Cédric; Contamin, Hugues; Vandenesch, François; Lina, Gérard; Gerard, Norma P; Gerard, Craig; van Kessel, Kok P M; Henry, Thomas; van Strijp, Jos A G.
Afiliación
  • Spaan AN; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands; Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France; Inserm, Unité 1111, 69007 Lyon, France;
  • Schiepers A; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • de Haas CJ; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • van Hooijdonk DD; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • Badiou C; Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France; Inserm, Unité 1111, 69007 Lyon, France; Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France;
  • Contamin H; Cynbiose, 69280 Marcy l'Etoile, France;
  • Vandenesch F; Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France; Inserm, Unité 1111, 69007 Lyon, France; Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France; Centre National de Référence des St
  • Lina G; Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France; Inserm, Unité 1111, 69007 Lyon, France; Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France; Centre National de Référence des St
  • Gerard NP; Ina Sue Perlmutter Laboratory, Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115; and Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.
  • Gerard C; Ina Sue Perlmutter Laboratory, Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, Department of Medicine, Harvard Medical School, Boston, MA 02115; and.
  • van Kessel KP; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands;
  • Henry T; Centre International de Recherche en Infectiologie, Université Lyon 1 and Ecole Normale Supérieure de Lyon, 69007 Lyon, France; Inserm, Unité 1111, 69007 Lyon, France; Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5308, 69007 Lyon, France;
  • van Strijp JA; Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands; j.vanstrijp@umcutrecht.nl.
J Immunol ; 195(3): 1034-43, 2015 Aug 01.
Article en En | MEDLINE | ID: mdl-26091719
ABSTRACT
Staphylococcus aureus is well adapted to the human host. Evasion of the host phagocyte response is critical for successful infection. The staphylococcal bicomponent pore-forming toxins Panton-Valentine leukocidin LukSF-PV (PVL) and γ-hemolysin CB (HlgCB) target human phagocytes through interaction with the complement receptors C5aR1 and C5aR2. Currently, the apparent redundancy of both toxins cannot be adequately addressed in experimental models of infection because mice are resistant to PVL and HlgCB. The molecular basis for species specificity of the two toxins in animal models is not completely understood. We show that PVL and HlgCB feature distinct activity toward neutrophils of different mammalian species, where activity of PVL is found to be restricted to fewer species than that of HlgCB. Overexpression of various mammalian C5a receptors in HEK cells confirms that cytotoxicity toward neutrophils is driven by species-specific interactions of the toxins with C5aR1. By taking advantage of the species-specific engagement of the toxins with their receptors, we demonstrate that PVL and HlgCB differentially interact with human C5aR1 and C5aR2. In addition, binding studies illustrate that different parts of the receptor are involved in the initial binding of the toxin and the subsequent formation of lytic pores. These findings allow a better understanding of the molecular mechanism of pore formation. Finally, we show that the toxicity of PVL, but not of HlgCB, is neutralized by various C5aR1 antagonists. This study offers directions for the development of improved preclinical models for infection, as well as for the design of drugs antagonizing leukocidin toxicity.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Toxinas Bacterianas / Receptores de Quimiocina / Receptor de Anafilatoxina C5a / Exotoxinas / Proteínas Hemolisinas / Leucocidinas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Toxinas Bacterianas / Receptores de Quimiocina / Receptor de Anafilatoxina C5a / Exotoxinas / Proteínas Hemolisinas / Leucocidinas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Immunol Año: 2015 Tipo del documento: Article